Target intelligence / Profile preview

Lysosomal membrane and function

Molecular classification
Organelle, Cellular compartment, Enzyme family, Transporter family
01

Overview

The lysosome is a specialized membrane-bound organelle that serves as the primary degradative compartment of the cell, housing over 60 acidic hydrolases (Settembre et al., 2013, Nature Reviews Molecular Cell Biology). The lysosomal membrane is critical for maintaining an acidic luminal pH (4.5–5.0) through the action of V-ATPases and for regulating the efflux of catabolic products via specific transporters (Appelqvist et al., 2013, Journal of Molecular Cell Biology). Beyond waste disposal, the lysosome acts as a metabolic signaling hub, integrating nutrient sensing through the mTORC1 pathway (Wang et al., 2018, Trends in Cell Biology). Dysregulation of lysosomal function or membrane integrity is a hallmark of lysosomal storage diseases (LSDs), such as Gaucher and Pompe disease, and is increasingly implicated in neurodegenerative disorders like Parkinson's and Alzheimer's (Platt et al., 2018, Nature). Pharmacological interventions include enzyme replacement therapies, substrate reduction agents, and lysosomotropic drugs like hydroxychloroquine that alter luminal pH (Boya & Kroemer, 2008, Nature Reviews Drug Discovery). In oncology, the induction of lysosomal membrane permeabilization (LMP) is explored as a mechanism to bypass apoptosis resistance and trigger cathepsin-mediated cell death (Boya & Kroemer, 2008, Nature Reviews Drug Discovery).

Other names
LysosomeLysosomal compartmentLysosomal membrane permeabilizationLMPLysosomal system
02

Mechanism of action

Modulation of lysosomal pH, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), pharmacological chaperoning, or induction of lysosomal membrane permeabilization (LMP).

03

Biological functions

AutophagyProteolysisEndocytosisPhagocytosisNutrient sensingIon homeostasisMetabolic signaling
04

Disease associations

Lysosomal storage diseaseCancerNeurodegenerative diseaseAutoimmune diseaseInfection
05

Safety considerations

Drug-induced phospholipidosisRetinal toxicityLysosomal storageOff-target proteolysisImmune response to recombinant enzymes
06

Interacting drugs

Hydroxychloroquine

7 more in the full profile.

07

Biomarkers

Lysosome-associated membrane protein 1 (LAMP1)Lysosome-associated membrane protein 2 (LAMP2)Cathepsin BCathepsin DGlobotriaosylsphingosine (Lyso-Gb3)Glucosylsphingosine (Lyso-Gl1)

Beyond the preview

Go deeper on Lysosomal membrane and function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal membrane and function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call